T1	HMM 243 251	efficacy
T2	HMM 256 262	safety
T3	HMM 319 336	survival analyses
T4	HMM 349 355	safety
T5	HMM 666 684	antitumor activity
T6	HMM 689 696	safety.
T7	HMM 783 791	survival
T8	HMM 1032 1041	median OS
T9	HMM 1156 1158	OS
T10	HMM 1250 1308	Grade 3 or 4 fatigue, neutropenia, and febrile neutropenia
